ArticleNeuro-oncology2016
Multimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumab.
Ken Chang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
60 papers cite it
this paperpooled ittrialcites it